Shenzhen YHLO Biotech Co., Ltd.

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 2024-12-10			5-day change	1st Jan Change
17.65 ^CNY	+0.28%		-1.23%	-22.82%

Dec. 02	Shenzhen YHLO Biotech Gets Medical Device Registration for Hormone Assay Kit	MT
Nov. 28	Shenzhen YHLO Biotech Gets Medical Device Registrations from Hunan Administrator	MT

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Gets Medical Device Registration for Hormone Assay Kit	Dec. 02	MT
Shenzhen YHLO Biotech Gets Medical Device Registrations from Hunan Administrator	Nov. 28	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	Oct. 29	CI
Shanghai Long-Light Technology Co., Ltd. announced that it has received funding from Shenzhen YHLO Biotech Co., Ltd., Yanghe Capital Holding Group Limited	Oct. 07	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	Aug. 29	CI
Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2024.	May. 16	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
YHLO Biotech Secures US FDA Clearance for Two In-Vitro Diagnostics Products	Dec. 13	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shenzhen YHLO Biotech Co., Ltd.(XSSC:688575) added to S&P Global BMI Index	23-09-18	CI
YHLO Biotech Registers Reagent For Detecting Heart Failure	23-09-14	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2023.	23-05-16	CI
YHLO Biotech Unit Gets Certification for Two Medical Devices	23-05-10	MT
YHLO Biotech Unit Registers New Medical Device	23-05-04	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
YHLO Biotech Gets Registration Certificate for Automatic Biochemical Analyzer	23-04-05	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
YHLO Biotech Gets Registration Certificate for Anti-Desmoglein 3 Antibody Detection Kit	23-02-03	MT
YHLO Biotech's COVID-19 Antigen Kit Added to WHO's Emergency Use List	22-11-04	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Longlight announced that it has received $1.380000 million in funding from Shenzhen YHLO Biotech Co., Ltd., Yanghe Capital Holding Group Limited and other investors.	22-10-24	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-20	CI
Shenzhen YHLO Biotech Co., Ltd.(SHSE:688575) added to Shanghai Stock Exchange A Share Index	22-05-17	CI

Chart Shenzhen YHLO Biotech Co., Ltd.

Duration

Period

688575: Dynamic Chart

Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.

Employees

1,759

Sector

Medical Equipment, Supplies & Distribution

Calendar

2025-04-24 - Q4 2024 Earnings Release (Projected)

More about the company